Tabula Rasa HealthCare, Inc. (TRHC) — Financial statements
Income statement, balance sheet, and cash flow for Tabula Rasa HealthCare, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 300↓9.6% | 331↑11.5% | 297↑4.4% | 285↑39.4% | 204 | |
| Cost of Revenue | 233↓0.3% | 233↑13.9% | 205↑12.9% | 181↑31.7% | 138 | |
| Gross Profit | 67↓31.7% | 98↑5.9% | 92↓10.6% | 103↑55.2% | 67 | |
| Operating Expenses | ||||||
| R&D Expenses | 14↓26.8% | 20↑8.9% | 18↓16.4% | 22↑77.9% | 12 | |
| General & Administrative Expenses | 75↑1.6% | 74↑12.8% | 65↑28.5% | 51↑80.6% | 28 | |
| Selling & Marketing Expenses | 10↓59.6% | 26↑20.5% | 22↓14.7% | 25↑161.4% | 10 | |
| SG&A Expenses | 85↓14.3% | 100↑14.7% | 87↑14.1% | 76↑101.3% | 38 | |
| Other Expenses | 23↓51.1% | 48↑5.9% | 45↑31.4% | 34↑104.0% | 17 | |
| Operating Expenses | 123↓26.3% | 167↑11.4% | 150↑13.6% | 132↑97.7% | 67 | |
| Total Costs & Expenses | 356↓11.2% | 401↑12.9% | 355↑13.2% | 314↑53.3% | 205 | |
| Operating Results | ||||||
| Operating Income | -56↑18.7% | -69↓20.1% | -58↓100.2% | -29↑42.0% | -50 | |
| Depreciation & Amortization | 32↓33.5% | 48↑5.9% | 45↑31.4% | 34↑104.0% | 17 | |
| EBITDA | -27↓25.5% | -22↓6.2% | -20↓1350.8% | 2↓90.2% | 17 | |
| EBIT | -59↑15.1% | -69↑5.1% | -73↓100.3% | -36 | 0.00 | |
| Interest & Other Income | ||||||
| Net Interest Income | -9↑0.8% | -9↑56.1% | -21↓29.8% | -16↓1664.5% | -0.91 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 9↓0.8% | 9↓56.1% | 21↑29.8% | 16↑1664.5% | 0.91 | |
| Non-Operating Income | 2 | 0.00↓100.0% | 8↑100.6% | 4 | 0.00 | |
| Other Income / Expenses | -21↓125.8% | -9↑56.1% | -21↓29.8% | -16↓1664.5% | -0.91 | |
| Income Before Tax | -77↑1.9% | -78↑8.9% | -86↓77.1% | -49↑4.0% | -51 | |
| Income Tax Expense | 0.39↓38.0% | 0.63↑112.1% | -5↑68.1% | -16↓379.8% | -3 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -77↑2.2% | -79↑2.4% | -81↓149.6% | -32↑31.4% | -47 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -77↑2.2% | -79↑2.4% | -81↓149.6% | -32↑31.4% | -47 | |
| Bottom-Line Net Income | -77↑2.2% | -79↑2.4% | -81↓149.6% | -32↑31.4% | -47 | |
| EPS (Basic) | -3.18↑6.2% | -3.39↑8.6% | -3.71↓136.3% | -1.57↑36.7% | -2.48 | |
| EPS (Diluted) | -3.18↑6.2% | -3.39↑8.6% | -3.71↓136.3% | -1.57↑36.7% | -2.48 | |
| Weighted Average Shares | 24↑4.3% | 23↑6.8% | 22↑5.8% | 21↑8.0% | 19 | |
| Weighted Average Diluted Shares | 24↑4.3% | 23↑6.8% | 22↑5.8% | 21↑8.0% | 19 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.